Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer.

@article{Huang2009EfficacyAF,
  title={Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer.},
  author={Pin-I Huang and Yee Chao and Chung-Pin Li and R Z Lee and K K Chi and Cheng-Ying Shiau and Ling-wei Wang and Sang-Hue Yen},
  journal={International journal of radiation oncology, biology, physics},
  year={2009},
  volume={73 1},
  pages={159-65}
}
PURPOSE To evaluate the efficacy and prognostic factors of gemcitabine (GEM) concurrent chemoradiotherapy (CCRT) in patients with locally advanced pancreatic cancer. METHODS AND MATERIALS Between January 2002 and December 2005, 55 patients with locally advanced pancreatic cancer treated with GEM (400 mg/m(2)/wk) concurrently with radiotherapy (median dose, 50.4 Gy; range, 26-61.2) at Taipei Veterans General Hospital were enrolled. GEM (1,000 mg/m(2)) was continued after CCRT as maintenance… CONTINUE READING
10 Citations
27 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Similar Papers

Loading similar papers…